Evaluation of the post-COVID-19 functional status (PCFS) scale as a screening tool for sequelae in patients with COVID-19 hypoxic pulmonary disease

{
"level_sex_clusion_I": [
{
"value": "Male",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008297"
}
},
{
"value": "Female",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D005260"
}
}
],
"level_age_clusion_I": [
{
"value": "Middle Aged (45 to 64 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008875"
}
},
{
"value": "Aged (65 to 79 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000368"
}
},
{
"value": "Aged, 80 and over (80 years and more)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000369"
}
}
],
"level_type_clusion_I": [
"Patients population"
],
"level_type_clusion_other": "",
"clusion_I": "Adult patient, aged under 75 years, having been admitted to Nantes University Hospital for hypoxic pulmonary disease, defined by the need for supplemental oxygen therapy for at least 24 hours, associated with a diagnosis of SARS-CoV-2 infection confirmed by PCR or CT scan lesions consistent with infection in the event of a negative PCR, attending the 3 month follow-up visit, and having completed the PCFS and mMRC questionnaires. ",
"clusion_E": ""
}